Trust Point’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$389K Sell
1,049
-13
-1% -$4.59K 0.03% 314
2026
Q2
$381K Sell
1,062
-1,046
-50% -$320K 0.03% 283
2026
Q1
$528K Buy
2,108
+1
+0% +$249 0.05% 236
2025
Q4
$580K Sell
2,107
-176
-8% -$48.1K 0.05% 198
2025
Q3
$599K Buy
2,283
+278
+14% +$67.6K 0.05% 190
2025
Q2
$439K Sell
2,005
-783
-28% -$167K 0.04% 212
2025
Q1
$624K Sell
2,788
-395
-12% -$109K 0.06% 183
2024
Q4
$1.04M Buy
3,183
+2,427
+321% +$764K 0.07% 147
2024
Q3
$227K Sell
756
-27
-3% -$8.27K 0.02% 465
2024
Q2
$258K Sell
783
-83
-10% -$29.3K 0.02% 413
2024
Q1
$343K Buy
+866
New +$320K 0.03% 372

Other funds holding WST

Trust Point's WST Position: Q3 2026 in Review

Trust Point reduced its West Pharmaceutical (WST) stake by 1.2% in Q3 2026, selling an estimated $4.59K and leaving 1,049 shares worth $389K. The position accounts for 0.03% of the portfolio, ranked #314.

Trust Point first reported a position in WST in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.04M in Q4 2024. 716 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Trust Point held 1,049 shares of West Pharmaceutical worth $389K as of Q3 2026.
  • Trust Point sold 13 West Pharmaceutical shares in Q3 2026, an estimated $4.59K.
  • West Pharmaceutical made up 0.03% of Trust Point's portfolio in Q3 2026, its #314 holding.
  • Trust Point first reported a position in West Pharmaceutical in Q1 2024 and has held it in 11 quarters since.
  • Trust Point's West Pharmaceutical position peaked at $1.04M in Q4 2024.
  • 716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.